| EN

Simcere’s oral PRMT5 inhibitor featured in an oral presentation of AACR annual meeting

Release time:2022-04-18

Voice on AACR!Simcere’s oral PRMT5 inhibitor  featured in an oral presentation of AACR annual meeting.

Dr. ZHOU Feng from Simcere Shanghai Innovation Center gave speech on SCR-6277,a potent and high selective arginine methyl-transferase 5(PRMT5) inhibitor with high tumor/ plasma distribution ratio demonstrated robust antitumor activities and decreased hematological toxicities.